Digital Storytelling in the NICU

Sponsor
Vanderbilt University (Other)
Overall Status
Completed
CT.gov ID
NCT04254718
Collaborator
(none)
6
1
1
8.6
0.7

Study Details

Study Description

Brief Summary

Our long-term goal is to reduce suffering and long-term negative consequences for families in the Neonatal Intensive Care Unit (NICU). The overall purpose of this study is to test feasibility of a legacy intervention for NICU parents.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Digital Storytelling
N/A

Detailed Description

Specific aims are:

(1) To determine the feasibility of a legacy intervention for NICU parents; and (2) to determine the feasibility of psychosocial instruments for NICU parents. We will recruit parents (N = 12) of 6 infants in the NICU who have received a palliative care consultation and expected to die by 1 year of age based on provider report. We will use a one-group pre- and post-test design. The intervention will be delivered by the PI or trained study staff conducting video-taped interviews with parents in private NICU rooms to create a digital story about their infant. The videographer will use the video and music selected by parents to create a digital story about the infant. The final digital story is provided to parents on a DVD or unlisted (private) YouTube link to keep. Parents will complete electronic psychosocial measures at enrollment (baseline/pre-intervention) and post-intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
6 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Preliminary Pilot Study of Digital Storytelling in the NICU
Actual Study Start Date :
Oct 12, 2020
Actual Primary Completion Date :
Jun 30, 2021
Actual Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Digital Storytelling

Legacy intervention via digital story for NICU parents

Behavioral: Digital Storytelling
Creation of a digital story about the infant with video and music selected by parents

Outcome Measures

Primary Outcome Measures

  1. Change in PROMIS Anxiety survey (short form) [Baseline and 1 month]

    The PROMIS Anxiety (short form) survey measures the extent of anxiety. The range is 5-40, higher scores indicate higher anxiety

  2. Change in PROMIS Depression Survey (short form) [Baseline and 1 month]

    The PROMIS Depression survey measures the extent of depression. The range is 5-40, with 5 being least depressed and 40 being the most depressed.

  3. Change in PROMIS Sleep Disturbance survey (short form) [Baseline and 1 month]

    The PROMIS Sleep Disturbance instruments assess self-reported perceptions of sleep quality, sleep depth, and restoration associated with sleep. Scores range from 4-20. Low scores indicate better sleep and high scores indicate worse sleep.

  4. Change in PROMIS Meaning and Purpose survey (short form) [Baseline and 1 month]

    The PROMIS Meaning and Purpose survey assess one's sense of life having purpose and that there are good reasons for living. Scores range from 6-30. Higher scores indicated perceptions of hopefulness, optimism, goal-directedness, and feelings that one's life is worthy.

  5. Change in Benefit Finding Scale [Baseline and 1 month]

    Benefit Finding Scale measures the degree of deriving positive growth from adversity. Scores range from 17-85 with high scores indicating more positive growth.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Parents of infants in the NICU who have received a palliative care consult and expected to die by 1 year of age based on provider report:

  • Parent caregivers (ages 18 years and up) of infants

  • Parents will be defined as the legal guardians who act in the role of the infant's primary and secondary parent caregivers based on parent self-report.

  • Able to speak and understand English

  • Absence of cognitive impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vanderbilt University Nolensville Tennessee United States 37135

Sponsors and Collaborators

  • Vanderbilt University

Investigators

  • Principal Investigator: Terrah Akard, PhD, Vanderbilt University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Terrah Akard, Associate Professor, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT04254718
Other Study ID Numbers:
  • 191469
First Posted:
Feb 5, 2020
Last Update Posted:
Sep 28, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Terrah Akard, Associate Professor, Vanderbilt University

Study Results

No Results Posted as of Sep 28, 2021